| Revenue | NOK 0 | — |
| EBITDA | NOK -148K | -106% |
| Net profit | NOK -146K | -164% |
| Total assets | NOK 57,8M | +21% |
| Equity | NOK 47,5M | +0% |
| Employees | 0 | — |
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | −0 | −0 |
| EBITDA | −72 | −148 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −72 | −148 |
| Net financials | 302 | 2 |
| Profit before tax | 230 | −146 |
| Tax | −0 | −0 |
| Net profit | 230 | −146 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 47 685 | 57 798 |
| Equity | 47 685 | 47 538 |
| Long-term debt | 0 | 10 260 |
| Short-term debt | 0 | 0 |
| Total debt | 0 | 10 260 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AB Observer | Observer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fürst Holding As | Company | 60.6% | 60.6% | 2024 |
Precuro As | Company | 18.6% | 18.6% | 2024 |
Sats På Helse As | Company | 10.9% | 10.9% | 2024 |
Intmed Danmark Aps | Company | 9.5% | 9.5% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Andreas Berre Eriksen | Observer | 0 companies |
| Erik Trondsen | Board of Directors | 0 companies |
| Ivar Andre Simonsen | Chairman | 0 companies |
| Ivar Kroghrud | Chairman | 0 companies |
| Marius Christensen | Board of Directors | 0 companies |
| Hans Jakob Collett Humlevik | Board of Directors | 0 companies |
| Erik Carl Rosness | Chairman | 0 companies |
| Jannike Rosén | Board of Directors | 0 companies |